Grantham, Mayo, Van Otterloo & Co (GMO)’s Helen of Troy HELE Stock Holding History
Bought
Maintained
Sold
Other funds holding HELE
CB
Grantham, Mayo, Van Otterloo & Co (GMO)'s HELE Position: Q2 2021 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Helen of Troy (HELE) in Q2 2021, closing a stake of 2,002 shares — an estimated $422K sold.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in HELE in Q4 2013 and held it in 24 quarters. The position peaked at $48.8M in Q2 2016. 287 funds tracked by Wall St. Rank hold HELE as of Q2 2021.
- Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Helen of Troy position as of Q2 2021 after selling out during the quarter.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 2,002 Helen of Troy shares in Q2 2021, an estimated $422K.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Helen of Troy in Q4 2013 and held it in 24 quarters.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Helen of Troy position peaked at $48.8M in Q2 2016.
- 287 funds tracked by Wall St. Rank held Helen of Troy as of Q2 2021.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2021, filed 12 Aug 2021.